FDA announced approval of Sutent, a new targeted anti-cancer treatment for patients with gastrointestinal stromal tumors, a rare stomach cancer, and advanced kidney cancer.
Researchers have found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them.
A new study looked at the benefits when clinicians counsel patients on their physical activity - and how routine assessments lower the risk of...
Heartland Food Products Group, makers of Splenda Sweeteners, is claiming that the recent CSPI rating on Sucralose is misleading to consumers. In response to the...
Researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors.
A study published by Nature has defined the function of p110 alpha, the flag-ship molecule of the eight member PI3K family, which is one of the most frequently activated pathways in cancer.
Heart disease and diabetes are among the most common conditions plaguing Americans today, and they are related to a host of other diseases. Research now also demonstrates that these conditions can be warning signs for some types of digestive cancers.
Researchers have shown that diabetes can cause chronic liver disease and cancer of the liver.
Nicotine By-Product Reacts with Proteins; May Contribute to The Pathology of Diabetes, Cancer, Aging,...
Two researchers have discovered that a chemical called nornicotine — which is naturally present in tobacco — may contribute to the pathology of diabetes, cancer, aging, and Alzheimer’s disease.
Doctors and patients should be aware of early warning signs for pancreatic cancer in people with diabetes, which has links to diabetes medications. Patients and...
Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer.
There are a number of risk factors shared between diabetes, ischemic heart disease, and several different types of cancer. In a major symposium at the...
An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study.
Nearly 6% of new cancer cases were caused by the combined effects of diabetes and being overweight or obese - and almost twice as common in women as men.
A drug widely used by cancer and transplant patients also comes with a downside: it leads to diabetes in as many as 15 percent of the people who take it.
1 in 120 people newly diagnosed with diabetes age 50 and older have a higher risk of developing pancreatic cancer--a risk that is eight times more than expected for the general population.